BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 16330774)

  • 1. Regulation of muscle growth by multiple ligands signaling through activin type II receptors.
    Lee SJ; Reed LA; Davies MV; Girgenrath S; Goad ME; Tomkinson KN; Wright JF; Barker C; Ehrmantraut G; Holmstrom J; Trowell B; Gertz B; Jiang MS; Sebald SM; Matzuk M; Li E; Liang LF; Quattlebaum E; Stotish RL; Wolfman NM
    Proc Natl Acad Sci U S A; 2005 Dec; 102(50):18117-22. PubMed ID: 16330774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional redundancy of type I and type II receptors in the regulation of skeletal muscle growth by myostatin and activin A.
    Lee SJ; Lehar A; Liu Y; Ly CH; Pham QM; Michaud M; Rydzik R; Youngstrom DW; Shen MM; Kaartinen V; Germain-Lee EL; Rando TA
    Proc Natl Acad Sci U S A; 2020 Dec; 117(49):30907-30917. PubMed ID: 33219121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting myostatin/activin A protects against skeletal muscle and bone loss during spaceflight.
    Lee SJ; Lehar A; Meir JU; Koch C; Morgan A; Warren LE; Rydzik R; Youngstrom DW; Chandok H; George J; Gogain J; Michaud M; Stoklasek TA; Liu Y; Germain-Lee EL
    Proc Natl Acad Sci U S A; 2020 Sep; 117(38):23942-23951. PubMed ID: 32900939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy.
    Morvan F; Rondeau JM; Zou C; Minetti G; Scheufler C; Scharenberg M; Jacobi C; Brebbia P; Ritter V; Toussaint G; Koelbing C; Leber X; Schilb A; Witte F; Lehmann S; Koch E; Geisse S; Glass DJ; Lach-Trifilieff E
    Proc Natl Acad Sci U S A; 2017 Nov; 114(47):12448-12453. PubMed ID: 29109273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of body mass growth through activin type IIB receptor in teleost fish.
    Carpio Y; Acosta J; Morales R; Santisteban Y; Sanchéz A; Estrada MP
    Gen Comp Endocrinol; 2009 Jan; 160(2):158-67. PubMed ID: 19056390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A soluble activin receptor type IIB does not improve blood glucose in streptozotocin-treated mice.
    Wang Q; Guo T; Portas J; McPherron AC
    Int J Biol Sci; 2015; 11(2):199-208. PubMed ID: 25561902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice.
    Allen DL; Cleary AS; Speaker KJ; Lindsay SF; Uyenishi J; Reed JM; Madden MC; Mehan RS
    Am J Physiol Endocrinol Metab; 2008 May; 294(5):E918-27. PubMed ID: 18334608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic identification and functional validation of activins and bone morphogenetic protein 11 as candidate novel muscle mass regulators.
    Souza TA; Chen X; Guo Y; Sava P; Zhang J; Hill JJ; Yaworsky PJ; Qiu Y
    Mol Endocrinol; 2008 Dec; 22(12):2689-702. PubMed ID: 18927237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia.
    Benny Klimek ME; Aydogdu T; Link MJ; Pons M; Koniaris LG; Zimmers TA
    Biochem Biophys Res Commun; 2010 Jan; 391(3):1548-54. PubMed ID: 20036643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of satellite cells versus myofibers in muscle hypertrophy induced by inhibition of the myostatin/activin signaling pathway.
    Lee SJ; Huynh TV; Lee YS; Sebald SM; Wilcox-Adelman SA; Iwamori N; Lepper C; Matzuk MM; Fan CM
    Proc Natl Acad Sci U S A; 2012 Aug; 109(35):E2353-60. PubMed ID: 22869749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activin receptor type 2A (ACVR2A) functions directly in osteoblasts as a negative regulator of bone mass.
    Goh BC; Singhal V; Herrera AJ; Tomlinson RE; Kim S; Faugere MC; Germain-Lee EL; Clemens TL; Lee SJ; DiGirolamo DJ
    J Biol Chem; 2017 Aug; 292(33):13809-13822. PubMed ID: 28659341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscle growth in teleost fish is regulated by factors utilizing the activin II B receptor.
    Phelps MP; Jaffe IM; Bradley TM
    J Exp Biol; 2013 Oct; 216(Pt 19):3742-50. PubMed ID: 23788712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A muscle growth-promoting treatment based on the attenuation of activin/myostatin signalling results in long-term testicular abnormalities.
    Vaughan D; Mitchell R; Kretz O; Chambers D; Lalowski M; Amthor H; Ritvos O; Pasternack A; Matsakas A; Vaiyapuri S; Huber TB; Denecke B; Mukherjee A; Widera D; Patel K
    Dis Model Mech; 2021 Feb; 14(2):. PubMed ID: 33408083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise restores decreased physical activity levels and increases markers of autophagy and oxidative capacity in myostatin/activin-blocked mdx mice.
    Hulmi JJ; Oliveira BM; Silvennoinen M; Hoogaars WM; Pasternack A; Kainulainen H; Ritvos O
    Am J Physiol Endocrinol Metab; 2013 Jul; 305(2):E171-82. PubMed ID: 23695214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic Blockade of ACVR2B Ligands Protects Myocardium from Acute Ischemia-Reperfusion Injury.
    Magga J; Vainio L; Kilpiö T; Hulmi JJ; Taponen S; Lin R; Räsänen M; Szabó Z; Gao E; Rahtu-Korpela L; Alakoski T; Ulvila J; Laitinen M; Pasternack A; Koch WJ; Alitalo K; Kivelä R; Ritvos O; Kerkelä R
    Mol Ther; 2019 Mar; 27(3):600-610. PubMed ID: 30765322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiling of skeletal muscles treated with a soluble activin type IIB receptor.
    Rahimov F; King OD; Warsing LC; Powell RE; Emerson CP; Kunkel LM; Wagner KR
    Physiol Genomics; 2011 Apr; 43(8):398-407. PubMed ID: 21266502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and functional characterizations of activin type 2B receptor (acvr2b) ortholog from the marine fish, gilthead sea bream, Sparus aurata: evidence for gene duplication of acvr2b in fish.
    Funkenstein B; Krol E; Esterin E; Kim YS
    J Mol Endocrinol; 2012 Dec; 49(3):175-92. PubMed ID: 22911153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of myostatin signaling by c-Jun N-terminal kinase in C2C12 cells.
    Huang Z; Chen D; Zhang K; Yu B; Chen X; Meng J
    Cell Signal; 2007 Nov; 19(11):2286-95. PubMed ID: 17689926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myostatin/activin blocking combined with exercise reconditions skeletal muscle expression profile of mdx mice.
    Kainulainen H; Papaioannou KG; Silvennoinen M; Autio R; Saarela J; Oliveira BM; Nyqvist M; Pasternack A; 't Hoen PA; Kujala UM; Ritvos O; Hulmi JJ
    Mol Cell Endocrinol; 2015 Jan; 399():131-42. PubMed ID: 25304272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific targeting of TGF-β family ligands demonstrates distinct roles in the regulation of muscle mass in health and disease.
    Chen JL; Walton KL; Hagg A; Colgan TD; Johnson K; Qian H; Gregorevic P; Harrison CA
    Proc Natl Acad Sci U S A; 2017 Jun; 114(26):E5266-E5275. PubMed ID: 28607086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.